Blood Fatty Acid Profiles: New Biomarkers for Cardiometabolic Disease Risk

Kristina H. Jackson, William Harris

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Purpose of Review: Fatty acid (FA) profiles in different blood compartments are reflections of both diet and metabolism, and some FA levels are related to disease risk. Recent Findings: Perhaps the most studied FA—disease relationship is between long-chain omega-3 polyunsaturated fatty acids [eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] and cardiovascular disease (CVD). Despite null results from recent large omega-3 FA supplementation trials, new research continues to support past studies showing that blood levels of EPA + DHA are inversely related to risk for total mortality and fatal CVD events. But blood levels of other FAs may also be useful markers of risk for a variety of diseases. The essential omega-6 FA linoleic acid is inversely associated with risk for developing type 2 diabetes (T2D), whereas risk for T2D is directly related to biomarkers of de novo lipogenesis (palmitic and palmitoleic acids). Levels of industrially produced trans FAs have been linked to higher risk for CVD. Summary: Thus, blood levels of several individual FAs are emerging as modifiable biomarkers for risk of major chronic diseases.

Original languageEnglish (US)
Article number22
JournalCurrent Atherosclerosis Reports
Volume20
Issue number5
DOIs
StatePublished - May 1 2018
Externally publishedYes

Fingerprint

Fatty Acids
Biomarkers
Cardiovascular Diseases
Eicosapentaenoic Acid
Docosahexaenoic Acids
Omega-3 Fatty Acids
Type 2 Diabetes Mellitus
Omega-6 Fatty Acids
Palmitic Acids
Lipogenesis
Essential Fatty Acids
Linoleic Acid
Unsaturated Fatty Acids
Chronic Disease
Diet
Mortality
Research

Keywords

  • Cardiovascular disease
  • Fatty acids
  • Mortality
  • Omega-3
  • Omega-6
  • Type 2 diabetes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Blood Fatty Acid Profiles : New Biomarkers for Cardiometabolic Disease Risk. / Jackson, Kristina H.; Harris, William.

In: Current Atherosclerosis Reports, Vol. 20, No. 5, 22, 01.05.2018.

Research output: Contribution to journalReview article

Jackson, Kristina H. ; Harris, William. / Blood Fatty Acid Profiles : New Biomarkers for Cardiometabolic Disease Risk. In: Current Atherosclerosis Reports. 2018 ; Vol. 20, No. 5.
@article{566f826b9a1a45aa9f8dfc5eeeeb2437,
title = "Blood Fatty Acid Profiles: New Biomarkers for Cardiometabolic Disease Risk",
abstract = "Purpose of Review: Fatty acid (FA) profiles in different blood compartments are reflections of both diet and metabolism, and some FA levels are related to disease risk. Recent Findings: Perhaps the most studied FA—disease relationship is between long-chain omega-3 polyunsaturated fatty acids [eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] and cardiovascular disease (CVD). Despite null results from recent large omega-3 FA supplementation trials, new research continues to support past studies showing that blood levels of EPA + DHA are inversely related to risk for total mortality and fatal CVD events. But blood levels of other FAs may also be useful markers of risk for a variety of diseases. The essential omega-6 FA linoleic acid is inversely associated with risk for developing type 2 diabetes (T2D), whereas risk for T2D is directly related to biomarkers of de novo lipogenesis (palmitic and palmitoleic acids). Levels of industrially produced trans FAs have been linked to higher risk for CVD. Summary: Thus, blood levels of several individual FAs are emerging as modifiable biomarkers for risk of major chronic diseases.",
keywords = "Cardiovascular disease, Fatty acids, Mortality, Omega-3, Omega-6, Type 2 diabetes",
author = "Jackson, {Kristina H.} and William Harris",
year = "2018",
month = "5",
day = "1",
doi = "10.1007/s11883-018-0722-1",
language = "English (US)",
volume = "20",
journal = "Current Atherosclerosis Reports",
issn = "1523-3804",
publisher = "Current Medicine Group",
number = "5",

}

TY - JOUR

T1 - Blood Fatty Acid Profiles

T2 - New Biomarkers for Cardiometabolic Disease Risk

AU - Jackson, Kristina H.

AU - Harris, William

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Purpose of Review: Fatty acid (FA) profiles in different blood compartments are reflections of both diet and metabolism, and some FA levels are related to disease risk. Recent Findings: Perhaps the most studied FA—disease relationship is between long-chain omega-3 polyunsaturated fatty acids [eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] and cardiovascular disease (CVD). Despite null results from recent large omega-3 FA supplementation trials, new research continues to support past studies showing that blood levels of EPA + DHA are inversely related to risk for total mortality and fatal CVD events. But blood levels of other FAs may also be useful markers of risk for a variety of diseases. The essential omega-6 FA linoleic acid is inversely associated with risk for developing type 2 diabetes (T2D), whereas risk for T2D is directly related to biomarkers of de novo lipogenesis (palmitic and palmitoleic acids). Levels of industrially produced trans FAs have been linked to higher risk for CVD. Summary: Thus, blood levels of several individual FAs are emerging as modifiable biomarkers for risk of major chronic diseases.

AB - Purpose of Review: Fatty acid (FA) profiles in different blood compartments are reflections of both diet and metabolism, and some FA levels are related to disease risk. Recent Findings: Perhaps the most studied FA—disease relationship is between long-chain omega-3 polyunsaturated fatty acids [eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] and cardiovascular disease (CVD). Despite null results from recent large omega-3 FA supplementation trials, new research continues to support past studies showing that blood levels of EPA + DHA are inversely related to risk for total mortality and fatal CVD events. But blood levels of other FAs may also be useful markers of risk for a variety of diseases. The essential omega-6 FA linoleic acid is inversely associated with risk for developing type 2 diabetes (T2D), whereas risk for T2D is directly related to biomarkers of de novo lipogenesis (palmitic and palmitoleic acids). Levels of industrially produced trans FAs have been linked to higher risk for CVD. Summary: Thus, blood levels of several individual FAs are emerging as modifiable biomarkers for risk of major chronic diseases.

KW - Cardiovascular disease

KW - Fatty acids

KW - Mortality

KW - Omega-3

KW - Omega-6

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85044302476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044302476&partnerID=8YFLogxK

U2 - 10.1007/s11883-018-0722-1

DO - 10.1007/s11883-018-0722-1

M3 - Review article

C2 - 29556735

AN - SCOPUS:85044302476

VL - 20

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

SN - 1523-3804

IS - 5

M1 - 22

ER -